Senior insider sale
Chief Financial Officer at EVOMMUNE, INC. — senior position signals high conviction
$599.3K
25.68K shares
What this filing means
CARVER KYLE plans to sell 25.68K shares of EVOMMUNE, INC. valued at approximately $599.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/28/2026ACC: 0001950047-26-005227
Officer· Chief Financial Officer
Since Nov 2025
25.68K
Shares to sell
$599.3K
Approx. market value
25.68K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
5/28/2026
22.50KPre-IPO Purchase of Common Shares
Cash
4/26/2023
3.17KTotal acquired25.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/28/2026 | Exercise of Stock Options Cash | 22.50K | — |
4/26/2023 | Pre-IPO Purchase of Common Shares Cash | 3.17K | — |
| Total | 25.68K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
25.68K
Market value
$599.3K
5/28/2026
Total
Units
25.68K
Value
$599.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/28/2026 | 25.68K | $599.3K | NYSE | Planned |
| Total | 25.68K | $599.3K | ||